GEHC inventory analysis suggests potential upside in FY16-17e
|
|
- Jade Walsh
- 5 years ago
- Views:
Transcription
1 Company update 15 October 2015 NANOSONICS (NAN) GEHC inventory analysis suggests potential upside in FY16-17e We are expecting a positive quarterly report from Nanosonics towards the end of this month, describing their first period with a fully operational US direct sales channel. Having reviewed our model, we see three potential ways for Nanosonics to beat our forecasts this year. We estimate that US partner GE Healthcare still has 1,000 Trophon devices which could be sold into hospitals over the next 12 months, boosting the US installed base and Nano s related consumables sales. GEHC could also resume their Trophon re-stocking orders, sooner than anticipated. Finally, the Q1 update could prompt upgrades to our direct US sales forecasts, which were set very conservatively last time. Price target revised to $1.72 per share. BUY rating maintained. Key points Model review ahead of Nanosonics Q1 report and 4C we are expecting Nanosonics to announce aspects of their quarterly performance towards the end of October. The result is closely watched; given this is the first period with the company s US direct sales channel in full force. Our Q1 revenue forecast is A$5.8m, more than half of which relates to consumables and services. Installed base update a key catalyst for FY16-17 estimates we estimate that US non-exclusive partner GE Healthcare (GEHC) has 1,000 or more Trophon units remaining in their inventory, which could be released to the US hospital market over the next 12 months. All additions to the US installed base drive Nanosonics incremental consumable Sonex-HL cartridge (and other) sales. At present we do not have these GEHC inventory units in our forward estimates. Recognising them in equal tranches over the next 12 months could add ~$2.3m and ~$3.5m to our FY16 and FY17 revenue forecasts, respectively. Forecasts we have increased our near term revenue forecasts reflecting higher direct US sales and revised (favourable) FX assumptions. Our earnings changes bring Nanosonics breakeven point forward by ~8 months into FY17. Valuation $1.72 price target set with reference to DCF analysis. We view ~30% TSR as enough justification to reiterate our BUY rating. Risks and catalysts Catalysts a) commercial partnering arrangements in new markets; b) guideline updates favouring automated disinfection; c) FX tailwinds; d) improving visibility on sales mix (products, geographies); e) installed base growth. Risks a) slower-than-forecast sales development; b) operating margin structure and development; c) market downgrades. Year-end June (AUD) FY14A FY15A FY16F FY17F FY18F NPAT rep ($m) NPAT norm ($m) Consensus NPAT ($m) EPS norm (cps) EPS growth (%) P/E norm (x) EV/EBITDA (x) FCF yield (%) DPS (cps) Dividend yield (%) Franking (%) Source: Company data, WHTM estimates, S&P Capital IQ 12-mth target price (AUD) $1.72 Share 14-Oct-15 (AUD) $1.34 Forecast 12-mth capital return 29.1% Forecast 12-mth dividend yield 0.0% 12-mth total shareholder return 29.1% Market cap $378m Enterprise value $342m Shares on issue 284m Sold short 1.6 ASX 300 weight 0.0% Median turnover/day Shane Storey shane.storey@wilsonhtm.com.au Tel Joseph Michael, CFA joseph.michael@wilsonhtm.com.au Tel $ mth share price performance NAN $0.4m 0.80 Sep-14 Jan-15 May-15 Sep-15 1-mth 6-mth 12-mth Abs return (%) Rel return (%) KEY CHANGES 03-Sep After Var % NPAT: FY16F N/A norm FY17F >99% ($m) FY18F >99% EPS: FY16F N/A norm FY17F >99% (cps) FY18F >99% DPS: FY16F % (cps) FY17F % FY18F % Price target: % Rating: BUY BUY XSI Rebased Wilson HTM Equities Research Issued by Wilson HTM Ltd ABN Australian Financial Services Licence No , a participant of ASX Group and should be read in conjunction with the disclosures and disclaimer in this report. Important disclosures regarding companies that are subject of this report and an explanation of recommendations can be found at the end of this document.
2 PRICE TARGET Valuation WACC (%) 12 Terminal growth (%) 6 NPV Forecast FCF (A$M) 79 NPV Perpetuity (A$M) 373 Net Debt/(Cash) (A$M) 36 DCF Valuation (A$M) 488 Growth options (A$M) 0.0 NAN valuation (A$M) Price Target KEY ASSUMPTIONS Revenue Growth (%) EBIT Growth (%) NPAT Growth (%) EPS Growth (%) EBIT / Sales (%) Tax Rate (%) ROA (%) ROE (%) Price target ($/sh) 1.72 INTERIMS ($m) Half-year (AUD) Dec 14 Jun 15 Dec 15 Jun 16 1HA 2HA 1HE 2HE Sales revenue EBITDA EBIT Net profit Norm EPS EBIT/sales (%) Dividend (c) Franking (%) FINANCIAL STABILITY Year-end June (AUD) FY15A FY16F FY17F Net debt Net debt/equity (%) <0 <0 <0 Net debt/ev (%) <0 <0 <0 Current ratio (x) Interest cover (x) <0 Adj cash int cover (x) <0 Debt/cash flow (x) < Net debt (cash)/share ($) <0 <0 <0 NTA/share ($) Book value/share ($) Payout ratio (%) Adj payout ratio (%) EPS RECONCILIATION ($m) FY15A FY16F Rep Norm Rep Norm Sales revenue EBIT Net profit Notional earn Pref/conv div Profit for EPS Diluted shrs (m) Diluted EPS (c) RETURNS FY15A FY16F FY17F FY18F ROE (%) ROIC (%) Incremental ROE Incremental ROIC ,542.8 PROFIT AND LOSS ($m) Sales revenue EBITDA Depn & amort EBIT Net interest expense Tax Minorities/pref divs Equity accounted NPAT Net profit (pre-sig items) Abns/exts/signif Reported net profit CASH FLOW ($m) EBITDA Interest & tax Working cap/other Operating cash flow Maintenance capex Free cash flow Dividends paid Growth capex Invest/disposals Other inv flows Cash flow pre-financing Funded by equity Funded by debt Funded by cash BALANCE SHEET SUMMARY ($m) Cash Current receivables Current inventories Net PPE Investments Intangibles/capitalised Other Total assets Current payables Total debt Other liabilities Total liabilities Minorities/convertibles Shareholder equity Total funds employed Wilson HTM Equities Research 2
3 Model review ahead of Q1 updates Forecast revisions due to modest volume estimate increases and FX changes The table below sets out the changes to our Nanosonics forecasts following our recent FX updates. We have also made small upgrades to our US Trophon volume forecasts. Table 1: Changes to FY16e and FY17e forecasts Source: WHTM Research FY16e Previous Current %chg Previous Current %chg Sales revenue $m % % COGS $m % % Gross profit $m % % Gross margin % 72.0% 73.2% 1% 72.3% 73.9% 2% Opex $m % % EBITDA $m % % D&A $m % % EBIT $m % % Net interest $m % % Tax $m NPAT $m % % EPS cps % % DPS cps FY17e Upside profile We have kept our forecasts relatively conservative, heading into the Q1 report, which will describe the first full trading period for Nanosonics US-based, direct sales force. A number of factors could influence our forecasts positively over the next few reporting periods. Q1 report expected late October we are forecasting A$5.8m revenue for Q1, featuring higher gross margins given the increased proportion of consumables and service revenue in the mix. We understand that service contracts and other SKUs outside the consumable, Sonex-HL hydrogen peroxide cartridges, are as high as 10% of revenues, and tend to grow in line with the installed base. With US direct sales just ramping up and no expected sales to GE Healthcare (GEHC) in Q1, we calculate consumables and services contributing ~56% of revenue in the quarter. Installed base update a potential driver of upgrades at the FY15 results Nanosonics described the US installed base as more than 5,000 Trophon units. The majority of these devices have been placed into clinics by GEHC, with or without Nanosonics marketing assistance. We estimate that GEHC could have approximately 1,000 Trophons remaining in their inventory, which could be released to the hospital market over the next 12 months (GEHC s timing and inclination both uncertain). All additions to the installed base drive incremental Sonex-HL cartridge sales. At present we do not have these GEHC inventory units in our forward installed base forecasts. Adding them in equal tranches over the next 12 months would add ~$2.3m and ~$3.5m to our FY16 and FY17 revenue forecasts. Table 1: GEHC could have as many as 1,000 Trophons to release into the US market, which could increase the installed base and consumables sales over the next year. 1HFY11 2HFY11 1HFY12 2HFY12 1HFY13 2HFY13 1HFY14 2HFY14 1HFY15 TOTAL US reported sales (A$m) US reported sales (US$m) Estimated Trophon EPR sales (US$m) Average Trophon EPR selling price (US$ net to Nanosonics) 5,500 Implied Trophon EPR unit sales 6,596 - less approximate US installed base 5,500 GEHC inventory (Trophon units) 1,096 Source: WHTM Research Wilson HTM Equities Research 3
4 GEHC s inventory clearance a potential catalyst for resumption of Trophon purchasing GEHC may resume purchasing Trophons from Nanosonics once inventories are worked down. GEHC sold approximately 500 Trophons into the market in the Q4FY15 period suggesting that they could have organic, clinic-level demand for as many as 2,000 units, annually, with no growth. We have modelled no sales to GEHC in FY16, given where we think GEHC s inventory levels currently sit. We have modest GEHC sales commencing this time next year (2HFY17), finally helping sustain US volume growth at 40% or above in the outer years (FY19 onwards). Valuation To set our $1.72 per share price target we use a discounted cash flow methodology. We maintain a BUY rating given the upside to our revised target price. Table 2: Forecast and valuation framework for Nanosonics FY15E FY16E FY17E FY18E FY19E FY20E FY21E FY22E Market data (units) Average global installed base (epr trophons) 5,731 7,277 9,359 11,777 15,031 19,676 26,313 35,802 Sonex cycles, millions Utilisation (cycles/trophon/day) Revenue (AUDm) grow th 3.4% 35% 27% 26% 34% 36% 40% 40% Gross Profit gross margin 69% 73% 74% 75% 76% 76% 76% 76% Operating items US SG&A Other expenses expense grow th 15% 31% 0% 8% 5% 6% 6% 6% EBITDA (4.7) (4.2) operating margin 17% 30% 40% 49% 56% NPAT (5.5) (4.3) EPS (2.0) (1.5) EPS grow th 338% 146% 89% 30% 48% Free cash flow (5.2) (0.1) Valuation PV of FCFF = 78.7 WACC 12.0% PV of Terminal Value = Tg 3% Value of Operating Assets = Net debt (cash) 36.1 Value of Equity = Value of Equity per share = 1.72 Source: WHTM Research Wilson HTM Equities Research 4
5 (NAN) BUSINESS DESCRIPTION (NAN) develops, manufactures and markets equipment for the high level disinfection of ultrasound probes and other pieces of medical device hardware. Its products are underpinned by a NanoNebulant technology very fine, nebulised droplets of concentrated hydrogen peroxide which kill microorganisms on surfaces. Its lead product, the Trophon EPR, is now available in most major markets for disinfecting obstetrics/gynaecologic probes. INVESTMENT THESIS Our thesis on Nanosonics is that, in time, regulatory pressure will build within the radiology industry to provide greater safety and traceability. This should entail a shift away from the use of toxic, bulk liquid disinfection practices. REVENUE DRIVERS Has a non-exclusive distribution arrangement with GEHC for the US and Canadian markets Network of third-party device distributors in Europe Revenue a function of both device sales (capital equipment) and consumables (cartridges of hydrogen peroxide and other products used with every disinfection cycle) MARGIN DRIVERS Gross margins: devices (c.60-75%); consumables (c.80-90%) Contract pricing may be variable Business development expenses expected in both Europe and US business building channels, increasing awareness, providing additional customer support KEY ISSUES/CATALYSTS Upside risks: Faster-than-expected sales traction in the US by GEHC Decision to scale-up manufacturing a leading indicator of demand Partnering transactions on other projects disinfection units for transesophageal transducers, other applications RISK TO VIEW Downside risks: Large partners like GEHC are slow to move Regulatory and/or clinical practice changes take a long time to change All device manufacturers face scale-up, quality control risks BALANCE SHEET Nanosonics had c.$45m cash as at end-fy15 BOARD Mr Maurie Stang (Non-Exec. Chairman) Dr Ron Weinberger (CEO, Executive Director) Mr Richard England (Non-Exec. Director) Dr David Fisher (Non-Exec. Director) Mr Michael Kavanagh (Non-Exec. Director) MANAGEMENT Mr Michael Kavanagh (CEO, Executive Director) Mr McGregor Grant (CFO) CONTACT DETAILS Address: Unit 24, 566 Gardeners Rd, Alexandria NSW 2015, Australia Phone: Website: Wilson HTM Equities Research 5
6 Disclosures and disclaimers Recommendation structure and other definitions Definitions at Disclaimer While Wilson HTM Ltd believes the information contained in this communication is based on reliable information, no warranty is give n as to its accuracy and persons relying on this information do so at their own risk. To the extent permitted by law Wilson HTM Ltd disclaims all liability to any person relying on the information contained in this communication in respect of any loss or damage (including consequential loss or damage) however caused, which may be suffered or arise directly or indirectly in respect of such information. Any projections contained in this communication are estimates only. Such projections are subject to market influences and contingent upon matters outside the c ontrol of Wilson HTM Ltd and therefore may not be realised in the future. The advice contained in this document is general advice. It has been prepared without taking account of any person s objectives, financial situation or needs and because of that, any person should, before acting on the advice, consider the appropriateness of the advice, having regard to the client s objectives, financial situation and needs. Those acting upon such information without first consulting one of Wilson HTM Ltd investment advisors do so entirely at their own risk. This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment whatsoever. If the advice relates to the acquisition, or possible acquisition, of a particular financial product the client should obtain a Product Disclosure Statement relating to the product and consider the Statement before making any decision about whether to acquire the product. This communication is not to be disclosed in whole or part or used by any other party without Wilson HTM Ltd s prior written consent. Disclosure of interest. The Directors of Wilson HTM Ltd advise that at the date of this report they and their associates have relevant interests in. They also advise that Wilson HTM Ltd and Wilson HTM Corporate Finance Ltd A.B.N and their associates have received and may receive commissions or fees from in relation to advice or dealings in securities. Some or all of Wilson HTM Ltd authorised representatives may be remunerated wholly or partly by way of commission. In producing research reports, members of Wilson HTM Ltd Research may attend site visits and other meetings hosted by the issuers the subject of its research reports. In some instances the costs of such site visits or meetings may be met in part or in whole by the issuers concerned if Wilson HTM Ltd considers it is appropriate and reasonable in the specific circumstances relating to the site visit or meeting. Please see disclosures at Disclosures applicable to companies included in this report can be found in the latest relevant published research. Wilson HTM national offices BRISBANE Ph: MELBOURNE Ph: SYDNEY Ph: DALBY Ph: GOLD COAST Ph: HERVEY BAY Ph: SUNSHINE COAST Ph: Website: Wilson HTM Equities Research 6
Nanosonics (NAN) BUY: Updating model for US consumables resupply bonus. Key points. Risks and catalysts
Date 03 October 2017 Theme Company Update Company Nanosonics (NAN) BUY: Updating model for US consumables resupply bonus We maintain our BUY rating with a revised price target of $3.34 per share. A new
More informationIDE submission for OncoSil
Company update 21 January 2016 ONCOSIL MEDICAL (OSL) IDE submission for OncoSil Oncosil Medical has made its first submission to the FDA, seeking approval to trial its brachytherapy device for the treatment
More informationUNIVERSAL BIOSENSORS INC. (UBI)
Low Return High Company Update 31 October 2013 UNIVERSAL BIOSENSORS INC. (UBI) ACTION & RECOMMENDATION Disruption from LifeScan s OneTouch Verio recall appears to have spilled over into Q3. Separately,
More informationCogstate Ltd. (CGS) Summary (AUD) Key Financials (A$ million) Share Price Graph (AUD)
Cogstate Ltd. (CGS) 7 August, 2017 Outperform 4Q17: Slow Growth, but CGS is Well-Positioned Price Target: $1.27 Elyse Shapiro eshapiro@taylorcollison.com.au +61 4 9126 7142 Summary (AUD) Market Capitalisation
More informationNanosonics Limited (ASX:NAN) AusBiotech Investment Summit Oct., 2011
Nanosonics Limited (ASX:NAN) AusBiotech Investment Summit Oct., 2011 Nanosonics Limited Founded in 2000 and ASX listed in 2007 Developed a range of low temperature disinfection and sterilisation technologies
More informationFY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski
FY2015 Results Presentation CEO & Managing Director - Julian Ogrin CFO - Leanne Wolski 21 August 2015 Important notice and disclaimer This presentation includes information about the activities of amaysim
More informationFor personal use only
Investor Presentation July 2015 experience is the difference Corporate Snapshot Capital Structure Share Price (20 July 2015) $1.91 Fully paid ordinary shares 133.1m Options 0.0m Market Capitalisation $254.2m
More informationFor personal use only. Traffic Technologies Ltd Investor Presentation 29 January 2014
Traffic Technologies Ltd Investor Presentation 29 January 2014 H1 14 EARNINGS GUIDANCE H1 14 EARNINGS GUIDANCE Earnings Guidance - Half Year to 31 Dec 2013 Half Year Ended 31 Dec 2013 ($m) 31 Dec 2012
More informationMatahari Putra Prima Company Focus
January 26, 2015 Matahari Putra Prima Company Focus More Challenging Expansion Changes to estimates We lowered our 2015E/2016E core EPS by 4.5/-13.0% due to lower expected number of new stores. Our new
More informationFY16 AGM Rob Woolley, Chair Laura McBain, CEO 19 October 2016
FY16 AGM Rob Woolley, Chair Laura McBain, CEO 19 October 2016 SHARE PRICE $ 18 16 14 12 10 8 6 4 2 0 05-Aug-14 30-Aug-14 30-Sep-14 31-Oct-14 30-Nov-14 31-Dec-14 31-Jan-15 28-Feb-15 31-Mar-15 30-Apr-15
More informationVOCATION LIMITED FY14 RESULTS PRESENTATION
VOCATION LIMITED FY14 RESULTS PRESENTATION August 2014 Important Notice and Disclaimer The material in this presentation has been prepared by Vocation Limited ABN 95 166 631 330 ("Vocation") and is general
More informationSENETAS 2017 INTERIM RESULTS. 27 February 2017
SENETAS 2017 INTERIM RESULTS 27 February 2017 AGENDA 1. HY17 HIGHLIGHTS 2. KEY FINANCIALS 3. OPERATIONAL REVIEW 4. OUTLOOK HY17 HIGHLIGHTS HY17 highlights Operating revenue up 8% Profit before tax down
More informationPark Group FY12 results
Park Group FY12 results Strong flexecard progress Financial services PBT, adjusted for the non-cash amortisation of acquired customer lists, was 7% ahead of our forecast ( 9.3m vs 8.7m forecast) and ahead
More informationFY16 FULL YEAR FINANCIAL RESULTS
FY16 FULL YEAR FINANCIAL RESULTS 30 AUGUST 2016 INVESTOR PRESENTATION Ryan d Almeida (CEO) Phil Wiltshire (CFO) FY16 Financial Highlights 1. 2. 3. 4. 5. 6. 7. IPO Prospectus forecasts for pro forma revenue,
More informationFor personal use only
ASX RELEASE APPENDIX 4C & OPERATIONAL UPDATE MSL DELIVERS GROWTH 26 July 2018: MSL Solutions Limited (ASX: MPW) (MSL or the Company) has today lodged its Report and is pleased to provide an update on the
More informationInitiating Coverage: ACCUMULATE HINDUSTAN PETROLEUM CORPORATION LTD
GMR s throughput to be boost by 65% because of refinery upgrades. The company is focused on increasing margins, the earning visibility is high, & the valuations of the company are attractive. Key Takeaways
More informationNanosonics Limited 2016 Half Year Results Investor Presentation
Nanosonics Limited 2016 Half Year Results Investor Presentation Michael Kavanagh McGregor Grant CEO & President Chief Financial Officer Disclaimer This presentation is intended to provide a general outline
More informationDOING BUSINESS IN CHINA 27 OCTOBER 2017
DOING BUSINESS IN CHINA 27 OCTOBER 2017 DISCLAIMER - This presentation is intended to constitute a summary of certain information about Synlait Milk Limited (Synlait). It should be read in conjunction
More informationFY18 RESULTS PRESENTATION
FY18 RESULTS PRESENTATION DISCLAIMER This presentation has been prepared by rhipe Limited ACN 112 452 436 (RHP). Each Recipient of this presentation is deemed to have agreed to accept the qualifications,
More informationOM HOLDINGS LIMITED Investor Presentation May 2018
1 OM HOLDINGS LIMITED Investor Presentation May 2018 2 DISCLAIMER This presentation has been prepared and issued by OM Holdings Limited ARBN 081 028 337 ( OMH ). This presentation contains summary information
More information2013 Half Year Results Presentation
2013 Half Year Results Presentation Ending March 31 st 2013 Adrian Di Marco Adrian_Dimarco@TechnologyOneCorp.com Commercial in confidence TechnologyOne Half Year Technology One Ltd Half Year Presentation
More informationFor personal use only
For personal use only FIRST HALF RESULTS AND GUIDANCE UPDATE 31 Dec 2015 25/2/16 Brian Shanahan CEO and Co-Founder Deborah Kelly Group CFO Summary: Proforma First Half Results FY16 Temple & Webster is
More information18 March Owen Venter Company Secretary ABN Drummond Place West Perth WA 6005
ABN 69 008 778 925 1 Drummond Place West Perth WA 6005 Postal Address PO Box 400 West Perth Western Australia 6872 Telephone (08) 9422 1100 Facsimile (08) 9227 8000 Email corporate@ctilogistics.com Web
More informationExtreme Networks FQ1 19 Financial Results
Extreme Networks FQ1 19 Financial Results November 2, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,
More informationFor personal use only
etivity AGM 31 May 2016 ASX code: COM www.comops.biz comops.com.au ComOps - Corporate Overview ComOps Limited (www.comops.com.au) ASX code GICS code Business Brands Customers Industry sectors COM Software
More informationFor personal use only. Company Update
Company Update May 2016 Company Highlights Vmoto is a global electric scooter manufacturer and distribution group Growing sales and underlying profits over FY2013 to FY2015 Wide China sales channels with
More informationInvestor Presentation
Tony Toohey CEO & Managing Director Investor Presentation August, 2013 1 Disclaimer This document and any oral presentation accompanying it has been prepared in good faith. However, no express or implied
More informationFor personal use only
Agenda 1H17 Financial Overview 1H17 Operational Overview Growth Plan and Outlook Growth Plan Detail Appendices Agenda 1H17 Financial Overview 1H17 Operational Overview Growth Plan Appendices 1H17 Financial
More informationAUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED BBY EMERGING COMPANIES CONFERENCE 24 JUNE 2014
AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED BBY EMERGING COMPANIES CONFERENCE 24 JUNE 2014 API snapshot API is a leading health and beauty retailer and franchise partner. The key assets: Priceline Pharmacy
More informationFY18 Results. Mark Coulter CEO Mark Tayler CFO
FY18 Results Mark Coulter CEO Mark Tayler CFO Page 1 Contents CEO Update Page 3-15 FY18 Financial Results Page 16-20 Strategy & Outlook Page 21 24 Q&A Page 2 CEO Update Mark Coulter CEO Pg 26 Page 3 Summary
More informationExtreme Networks FQ2 18 Financial Results
Extreme Networks FQ2 18 Financial Results February 6, 2018 Cautionary Statement on Financial Measures Non-GAAP Measures: In preparing the accompanying information, the Company has excluded, where applicable,
More informationH1FY19 Investor Presentation. Mark Coulter CEO Mark Tayler CFO
H1FY19 Investor Presentation Mark Coulter CEO Mark Tayler CFO Page 1 H1 Summary Pre Audit H1FY19 Revenue $49.3m 40% Growth YoY H1FY18 Revenue $35.2m Temple & Webster is the online market leader in furniture
More informationNotion VTec Berhad. 52-week price range RM
11 November 2009 4Q FY Sept 2009 Final Results Notion VTec Berhad Very strong 4QFY09 and final results Expect 40% net profit growth in FY10 New customers, products, expansion to drive growth FY10 forecasts
More informationFor personal use only
Integrated Research Limited (IRI) FY2019 Half Year Financial Results February 2019 Peter Adams, Interim CEO 9 of the Top 10 US banks 125+ of the Fortune 500 6 of the Top 10 Automotive Companies 7 of the
More informationFor personal use only
RXP Services Annual General Meeting 19 October 2016 Items of Business A. Chairman and CEO Presentations 1. Discussion of Financial Statements and Reports 2. Consideration of Remuneration Report 3. Consideration
More information2017 annual general meeting. 27 October 2017
2017 annual general meeting 27 October 2017 Andrew Reitzer Chairman 2 Board of directors Julian Ogrin Maria Martin 3 Board of directors Jodie Sangster Thorsten Kraemer 4 Board of directors Rolf Hansen
More informationService Stream Limited Managing Director s AGM Presentation
Service Stream Limited Managing Director s AGM Presentation Leigh Mackender 18 October 2017 Agenda 1 Company Profile 2 FY17 Group Performance 3 Business Unit Update 4 Group Strategy & Outlook 5 Questions
More informationInvestment Proposal. March 19th, Jenny Park Arthi Sairam. LinkedIn Corporation (NYSE- LNKD)
Investment Proposal LinkedIn Corporation (NYSE- LNKD) March 19th, 2016 Jenny Park Arthi Sairam Agenda I. Executive Summary II. Business Overview A. Company Overview B. Free Solutions C. Monetized Solutions
More informationMYOB Presentation and Video at Macquarie Australia Conference
6 May 2016 Market Announcements Office ASX Limited MYOB Presentation and Video at Macquarie Australia Conference MYOB Group Ltd (ASX: MYO) presented at the Macquarie Australia Conference, held on 4 May
More informationFor personal use only
Prophecy International Holdings Ltd. emite Acquisition EARNINGS UPDATE July 2015 1 Legal Disclaimer This presentation has been prepared by Prophecy International Holdings Limited. The information in this
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION SWISS EQUITIES CONFERENCE BAADER HELVEA R. ERNI, CFO BAD RAGAZ 12 JANUARY 2018 Panalpina Biz Model / Strategy Achievements and key figures Operating and financial review Appendix
More informationILUKA BRIEFING PAPER MODELLING METHODOLOGY June 2016
ILUKA BRIEFING PAPER MODELLING METHODOLOGY June 2016 Key Physical and Financial Parameters Iluka issued guidance on a range of parameters in its Key Physical and Financial Parameters of 19 February 2016).
More informationSOUTHERN CROSS AUSTEREO INVESTOR PRESENTATION TO MACQUARIE AUSTRALIA CONFERENCE 2018
ASX RELEASE 1 MAY 2018 SOUTHERN CROSS AUSTEREO INVESTOR PRESENTATION TO MACQUARIE AUSTRALIA CONFERENCE 2018 Please see attached a copy of the presentation being delivered by Grant Blackley to the 2018
More informationSpotless Group Holdings Limited FY14 Results Presentation
Spotless Group Holdings Limited FY14 Results Presentation 25 August 2014 Presenters: Bruce Dixon Chief Executive Officer & Managing Director Danny Agnoletto Chief Financial Officer Important Notices Important
More informationFor personal use only
Growth through scale and diversity Proposed merger between MyState and The Rock 31 August 2011 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO
More informationFinal Results. September 2016
Prophecy International Holdings Ltd. Final Results (12 months ended 30 June 2016) September 2016. $3.00 $2.25 Prophecy Corporate Overview $1.50 $0.75 $0.00 1- Aug- 14 26- Sep- 14 21- Nov- 14 16- Jan- 15
More informationFor personal use only MOBILE EMBRACE ASX: MBE. First Half 2016 Results. Chris Thorpe, CEO REACH ENGAGE TRANSACT EMBRACE 1
MOBILE EMBRACE ASX: MBE First Half 2016 Results Chris Thorpe, CEO 1 TABLE OF CONTENTS HALF YEAR UPDATE 1. 2016 FIRST HALF RESULTS (unaudited) 2. GROWTH & STRATEGY UPDATE p 4-8 p 9-16 APPENDIX 1. THE RAPID
More informationLEADER IN INFECTION CONTROL SOLUTIONS Transforming ultrasound probe disinfection
LEADER IN INFECTION CONTROL SOLUTIONS Transforming ultrasound probe disinfection ASX Asia Spotlight Conference Dr Ron Weinberger, Managing Director 16 & 18 October 2012 Disclaimer This presentation is
More informationIKE Investor Presentation.
IKE Investor Presentation. The growth opportunity for IKE via its IKE Analyze offering. Glenn Milnes, CEO & Chris Birkett, CFO. August, 2018 1 Table of contents 1. IKE update 2. IKE Analyze explained 3.
More informationFor personal use only
FAIRFAX OF THE FUTURE SYDNEY, 18 June 2012: Fairfax Media Limited [ASX:FXJ] has today announced fundamental changes to the Company. The changes are focused on three objectives: Positioning the Metro Media
More informationFAIRFAX OF THE FUTURE
FAIRFAX OF THE FUTURE SYDNEY, 18 June 2012: Fairfax Media Limited [ASX:FXJ] has today announced fundamental changes to the Company. The changes are focused on three objectives: Positioning the Metro Media
More informationAdelaide Brighton Ltd Macquarie Australia Conference 2 May 2012
Adelaide Brighton Ltd Macquarie Australia Conference 2 May 2012 Adelaide Brighton Ltd Disclaimer The following presentation has been prepared by Adelaide Brighton Limited ACN 007 596 018 for information
More informationFor personal use only
AGM Presentation November 27 2014 Disclaimer Some of the statements in this presentation constitute forward looking statements. By their nature forward looking statements involve a number of risks, uncertainties
More informationSummary Financials Strong sales, L4L, margin and profit growth in FY11
0 Summary Financials Strong sales, L4L, margin and profit growth in FY11 FY11 ($ M) FY10 ($ M) Change Revenue 164.4 146.4 +12.3% Net Margin (%) (1) 71.1% 68.5% Total Expenses (%) 49.6% 47.1% Earnings Before
More informationFor personal use only
ASX RELEASE HIGHLIGHTS MSL SOLUTIONS PRODUCES STRONG Q3 CASH FLOW RESULT Operating cash flow of $1.3 million for the quarter, and $2.2 million for the financial yearto-date (unaudited, adjusted for one-off
More informationCopyrights 2018 by International Financial Modeling Institute
1 Copyrights 2018 by International Financial Modeling Institute Last Update: June 2018 2 PFM Body of Knowledge About PFM BOK Professional Financial Modeler (PFM) Certification Program has embodied strong
More informationInghams Group Limited
Inghams Group Limited 1H FY2017 Results Presentation 15 FEBRUARY 2017 Important notice and disclaimer Disclaimer The material in this presentation is general background information about the activities
More informationPARKERVISION, INC. Rating: STRONG BUY Target: $27. NASDAQ: PRKR - $7.15 (Intra-Day Price) Semiconductors Integrated Circuits
EGE INSTITUTIONAL RESEARCH REPORT RESEARCH UPDATE MARCH 27, 2008 PARKERVISION, INC. NASDAQ: PRKR - $7.15 (Intra-Day Price) Semiconductors Integrated Circuits PRKR Ranks In The Top-Ten Of The Patent Board
More informationMitchell Communication Group
Mitchell Communication Group Presentation to ASX Small to Mid Caps Conference, Singapore 27 May 2010 Presented by: Luke Littlefield - Chief Operating Officer nothing is beyond our reach. Agenda Company
More informationFor personal use only
ASX RELEASE 5 MAY 2016 SOUTHERN CROSS AUSTEREO INVESTOR PRESENTATION TO MACQUARIE AUSTRALIA CONFERENCE 2016 Please see attached a copy of the presentation being delivered by Grant Blackley to the 2016
More informationBIG UNLIMITED FY18 Q1 4C UPDATE OCT 2017
BIG UNLIMITED FY18 Q1 4C UPDATE OCT 2017 WHAT IS BIG BIG (ASX: BIG) is the parent company of Big Review TV Ltd. Big Review TV are innovative disruptors in the online video space. They are a video driven
More informationFor personal use only
ASX Market Disclosure Aconex Agrees to Acquire Conject and Launches Capital Raising Acquisition Will Provide Strong Construction Collaboration Market Footprint throughout Europe MELBOURNE, Australia, 17
More informationResults for the 52 weeks to 27 June Peter Birtles, Managing Director David Burns, Chief Financial Officer 21st August 2015
Results for the 52 weeks to 27 June 2015 Peter Birtles, Managing Director David Burns, Chief Financial Officer 21st August 2015 Contents 2014/15 Financial Results 2015/16 Outlook Group Strategy 2 Group
More informationTHOMSON REUTERS FIRST-QUARTER 2008 MAY 1, 2008
THOMSON REUTERS FIRST-QUARTER 2008 MAY 1, 2008 AGENDA WELCOME / INTRODUCTION FRANK GOLDEN STRATEGY / DRIVING RESULTS TOM GLOCER FINANCIAL REVIEW & 2008 OUTLOOK BOB DALEO Q & A 2 SPECIAL NOTE Safe Harbor
More informationFor personal use only
Presentation 5 July 2016 NZX: SPY ASX: SMP SHARE INFORMATION Issued Shares: 171,752,278 Please see attached Smartpay presentation presented by Bradley Gerdis, Managing Director, to Micro Equities Rising
More informationSmarTone Telecommunications Holdings Limited
SmarTone Telecommunications Holdings Limited FY18 Interim Results Presentation For the six months ended 31 December 2017 13 February 2018 1 Disclaimer It is not the intention to provide, and no reliance
More informationNet income of $7.2 million, or $0.04 per share, compared to net loss of $43.2 million, or
NEWS RELEASE Trading Symbol: TSX: SVM NYSE: SVM SILVERCORP FISCAL 2015 Q2 RESULTS: SILVER PRODUCTION UP 32%, NET INCOME OF $7.2 MILLION ($0.04 PER SHARE), CASH FLOW FROM OPERATIONS OF $20.1 MILLION ($0.12
More informationASX Spotlight Series May 2013
ASX Spotlight Series 14 16 May 2013 Company Overview Established in 1952 and listed on the ASX in 2005 Diversified business model Automotive and Logistics Largest Australasian automotive retailer by sales,
More informationFor personal use only
Financial Year 2016 Results Investor Presentation August 2016 Agenda Results Overview 3 Brand by Performance. 11 1. Fantastic Furniture 2. Plush 3. Original Mattress Factory Manufacturing.... 16 Financials...
More informationPerkinElmer Announces Financial Results for the First Quarter 2008
PerkinElmer Announces Financial Results for the First Quarter 2008 -- Revenue of $482 million, up 20% over the prior year -- EPS from continuing operations of $0.20; Adjusted EPS of $0.29, up 21% over
More informationASX Small & Mid-Cap Conference
ASX Small & Mid-Cap Conference 6 September 2018 Rob Goss Chief Financial Officer Audinate : bringing the IT revolution to the AV industry Dante technology distributes audio signals across computer networks
More informationCOLLABORATE PRESENTS AT SYDNEY SMALL CAP SHOWCASE
ASX ANNOUNCEMENT 9 MARCH 2017 COLLABORATE PRESENTS AT SYDNEY SMALL CAP SHOWCASE Collaborate Corporation Limited (ASX:CL8 or the Company) is pleased to release a copy of the presentation made at the Sydney
More informationFY17 Results Presentation
FY17 Results Presentation FY17 Results August 2017 Presentation 28 August 2017 1. RESULTS OVERVIEW FY17 Results Overview Sales growth Sales increased by $17.5m (7.1% on FY16) LFL Sales for the full year
More informationACQUISITION OF ACCESS DIGITAL NETWORKS ACQUISITION OF COMLINX ASSOCIATED CAPITAL RAISING OCTOBER 2018
IMPORTANT NOTICE AND DISCLAIMER ACQUISITION OF ACCESS DIGITAL NETWORKS ACQUISITION OF COMLINX ASSOCIATED CAPITAL RAISING OCTOBER 2018 NOTICE 2 IMPORTANT NOTICE IMPORTANT AND NOTICE DISCLAIMER AND DISCLAIMER
More informationDTI GROUP LTD DTI GROUP LTD Interim Results Presentation 26 February Interim Results Presentation [_] February 2017
DTI GROUP LTD 2019 Interim Results Presentation 26 February 2019 DTI GROUP LTD 2017 Interim Results Presentation [_] February 2017 PETER TAZEWELL Chief Executive Officer 1 Overview H1 FY19 Financial Operating
More informationFor personal use only
Investor Presentation September 2017 Executive Summary ComOps provides essential Optimisation and Workforce Management (WFM) solutions to a blue chip client base High margin, recurring revenue streams
More informationFIRST QUARTER RESULTS 2016 INVESTOR PRESENTATION
FIRST QUARTER RESULTS 2016 INVESTOR PRESENTATION THREE MONTH RESULTS 21 APRIL 2016 Highlights and key figures Operating and financial review Outlook and priorities Appendix FIRST QUARTER RESULTS 21 APRIL
More informationPreliminary Results January September 2014
Creating the Leading Digital Telco Preliminary Results January September 2014 November 10, 2014 Disclaimer This document contains statements that constitute forward-looking statements and expectations
More informationDISTIL BEVERAGES. A successful year of both profit growth. ..and cash generation. 8 June 2018 DIS.L
DISTIL BEVERAGES DIS.L 2.57p Market Cap: 12.8m SHARE PRICE (p) 4 3 2 1 Jun '17 Sep '17 Dec '17 Mar '18 12m high/low Source: LSE Data KEY INFORMATION Enterprise value Index/market Next news Gearing Interest
More informationDIGI.COM BHD (DIGI) 07/02/2014. TELECOMS INFRA AND NETWORK Ownership:
DIGI.COM BHD (DIGI) 7/2/214 Financial Year: 213 31-Dec-213 Latest Quarter: 31/12/213 Price: 5. Stock Category: Investment Grade Board: Main Board FBMKLCI: YES Industry: INFRASTRUCTURE PROJ Sub-Sector:
More informationFor personal use only
ASX RELEASE MSL SOLUTIONS CONTINUES TO EXPAND GLOBAL FOOTPRINT, DELIVER ON ITS GROWTH STRATEGY AND REAFFIRMS GUIDANCE FOR FY18 Highlights On-track to deliver FY18 targets; 20% of annual target revenue
More informationTIL LOGISTICS GROUP LIMITED FY18 RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2018
1 TIL LOGISTICS GROUP LIMITED FY18 RESULTS PRESENTATION FOR THE YEAR ENDED 30 JUNE 2018 ABOUT TIL LOGISTICS GROUP One of New Zealand s largest domestic freight and logistics platforms Nationwide network
More informationFor personal use only
29 June Attention: Kerrie Papamihal Assistant Manager, Listing Australian Stock Exchange Dear Kerrie Review of Pro Forma Balance Sheet Pendragon Capital hereby confirms that in preparation of the Investigating
More informationSTRUCTURAL REVIEW UPDATE
STRUCTURAL REVIEW UPDATE TABLE OF CONTENTS 1. Divestment Summary 2. Structural Review Process 3. Divestment Of Selected Brands 4. City Chic Retained 2 DIVESTMENT SUMMARY Following its Structural Review,
More informationFY18 FY17 change (1.4) (240.2)
1 2 3 4 FY18 FY17 % $m $m change Total Revenue 357.3 320.3 11.5% Share of Profits (Loss) (1.4) (1.2) (15.5%) Expenses (240.2) (216.2) (11.1%) Operating EBITDA 115.7 102.9 12.5% EBIT 89.5 86.1 3.9% Net
More informationPresentation Q4 2016/17. October, 2017
Presentation Q4 2016/17 October, 2017 FINANCIAL REPORT Q4 2016/17 Dustin at a Glance 200,000 hardware and software products sold online Net sales Software and services ~11% Hardware Clients Server Offline
More information(NYSE: ROK) Rating: BUY Price Target: $ Industry: Electrical Components and Equipment. Investment Action & Thesis. Key Investment Highlights
Rating: BUY Price Target: $81.50 Industry: Electrical Components and Equipment Close 9/28/2012 Price $69.55 52 Wk $53.06 - $84.71 Shares Out (mm) 141.1 Mkt. Cap(mm) $9,816.9 Source: Capital IQ Basic Information
More informationDraft 14 09/02/17 1 INDEPENDENT. ALWAYS.
Draft 14 09/02/17 1 INDEPENDENT. ALWAYS. SUMMARY INFORMATION This presentation contains summary information about Fairfax Media Limited and its activities current as at 22 February 2017. The information
More informationBaby Bunting Group. Best of breed growth ADD
Vol m Retail Australia Equity research November 22, 2015 ADD Current price: Target price: A$2.19 A$2.46 Previous target: A$ Up/downside: 12.2% Reuters: Bloomberg: Market cap: Average daily turnover: BBN.AX
More informationKwong Lung 2017 Results (8916.TW) April 2018
Kwong Lung 2017 Results (8916.TW) April 2018 Disclaimer This document is provided by Kwong Lung Enterprise Co., Ltd. (the "Company"). Except for the numbers and information included in the Company's financial
More informationDreamscape Networks Limited (DN8)
A record result across all key metrics Dreamscape Networks Limited (DN8) Dreamscape Networks Limited First half FY17 Results Presentation 23 February 2017 Our Vision Providing simple, innovative and affordable
More informationFor personal use only
ASX ANNOUNCEMENT 31.7.18 ASX Market Announcements Australian Securities Exchange Limited 20 Bridge Street SYDNEY NSW 2000 QUARTERLY REPORT APPENDIX 4C FOR THE PERIOD TO 30 JUNE 2018 Admedus Limited (ASX:AHZ)
More information2009 Full Year Result
2009 Full Year Result 23 February, 2010 Chief Executive Brendan Hopkins Chief Financial Officer Peter Myers Overview Result in line with guidance Strong cost outcome high operating leverage February/March
More information2016 Annual Financial Results
2016 Annual Financial Results Investor Presentation Ian Manocha, CEO Rob Grubb, CFO 14 March 2017 Agenda Annual Financial Results 2016 Results Analysis & Trends Other Achievements in 2016 Industry recognition
More informationMorgans QLD Conference
Morgans QLD Conference October 2018 Mike Veverka CEO and Founder Good Start to the Year FY2019 OUTLOOK $50m, $70m TTV GROWTH 20-25% REVENUE MARGIN 20-21% $50m, $80m, $100m EBIT MARGIN 44-46% Scalability
More informationFORWARD-LOOKING STATEMENTS
2013 RESULTS FORWARD-LOOKING STATEMENTS Some statements in this presentation are forward looking. They represent expectations for Datalex s business and involve risks and uncertainties. Datalex has based
More informationSmart Parking Limited ASX:SPZ AGM Presentation. CEO Paul Gillespie 10th November 2017
Smart Parking Limited ASX:SPZ AGM Presentation CEO Paul Gillespie 10th November 2017 Business Overview World-leading technology for parking design, development & management Management Services UK Profitable
More informationInvestor Presentation
Siemens Ltd., 2 www.siemens.co.in Disclaimer This presentation has been prepared solely for use at the investor/analyst presentation. By attending the meeting where this presentation is made, or by reading
More informationVeriFone Files Restated Reports
VeriFone Files Restated Reports SAN JOSE, Calif. -- August 19, 2008 --VeriFone Holdings Inc. (NYSE: PAY) today filed its amended and restated quarterly report on Form 10-Q/A for the fiscal quarters ended
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION Scott Thomson, President and CEO Kevin Parkes, Managing Director, Finning UK & Ireland Mauk Breukels, VP Investor Relations Toronto, Montreal September 17-18, 2018 Disclosures Forward-looking
More information